Financial Performance - Net profit attributable to shareholders for the first nine months of 2022 was ¥13,304,202.81, a decrease of 35.35% from ¥20,577,554.52 in the same period last year[15]. - Operating revenue for the first nine months of 2022 was ¥188,722,420.21, down 7.31% from ¥203,606,679.87 in the previous year[15]. - The company's operating profit for the period was CNY 14,450,950.99, a decrease of 38.69% from CNY 23,570,338.28 in the same period last year[23]. - The gross profit margin for the same period was 25.85%, down from 28.62% in the previous year, representing a decrease of 2.78 percentage points[20]. - The company reported a net profit margin of approximately 10.67% for the first nine months of 2022, down from 11.06% in the same period of 2021[49]. - The company reported a total profit of CNY 5,704,341.85 for Q3 2022, which is a decrease of about 42.9% compared to CNY 9,967,361.50 in Q3 2021[51]. - The net profit for Q3 2022 was CNY 4,923,907.23, compared to CNY 8,732,603.98 in Q3 2021, reflecting a decrease of approximately 43.5%[51]. - The total comprehensive income for Q3 2022 was CNY 4,923,907.23, down from CNY 8,732,603.98 in Q3 2021, indicating a decline of about 43.5%[52]. - The company reported a net profit for Q3 2022 of CNY 3,963,042.15, a decrease from CNY 6,450,705.97 in Q3 2021, representing a decline of approximately 38.6%[55]. Cash Flow and Liquidity - Cash flow from operating activities showed a net outflow of ¥11,212,845.00, a significant decline of 1,518.28% compared to a net inflow of ¥790,592.18 in the same period last year[15]. - The cash inflow from financing activities was CNY 84,254,772.63, a substantial increase of CNY 102,227,312.60 compared to a cash outflow of CNY 17,972,539.97 in the previous year[26]. - The net cash flow from operating activities for Q3 2022 was negative at CNY -11,212,845.00, compared to a positive CNY 790,592.18 in Q3 2021[59]. - Cash and cash equivalents at the end of Q3 2022 amounted to CNY 104,755,229.52, an increase from CNY 28,998,175.92 at the end of Q3 2021[60]. - The company incurred interest expenses of CNY 494,685.27 in Q3 2022, compared to CNY 342,250.69 in Q3 2021, marking an increase of approximately 44.6%[55]. - The company received tax refunds amounting to CNY 3,567,825.76 in Q3 2022, compared to CNY 1,391,935.37 in Q3 2021, indicating an increase of about 156.0%[59]. - The total cash inflow from financing activities increased to 119,099,056.60 CNY in 2022, compared to 15,000,000.00 CNY in 2021[63]. - The net increase in cash and cash equivalents for Q3 2022 was 73,810,920.97 CNY, compared to a decrease of -16,940,963.42 CNY in Q3 2021[63]. Assets and Liabilities - Total assets as of September 30, 2022, reached ¥486,520,061.84, an increase of 18.95% compared to ¥409,013,352.32 at the end of the previous year[15]. - The company's debt-to-asset ratio decreased to 24.95% from 34.35% year-on-year, indicating improved financial stability[15]. - The construction in progress increased by 63.31% to ¥16,822,716.52, reflecting increased investment in the R&D center[18]. - The company's cash and cash equivalents increased by 127.55% to ¥111,672,502.12, primarily due to cash received from issuing shares[17]. - Current liabilities decreased to CNY 118,878,249.94 in Q3 2022 from CNY 140,381,297.84 in Q4 2021, a reduction of 15.29%[43]. - Long-term liabilities decreased to CNY 9,590,350.23 in Q3 2022 from CNY 10,452,770.85 in Q4 2021, a decline of 8.25%[43]. - The total liabilities were not explicitly stated in the provided documents, but the company reported no significant litigation or arbitration matters during the reporting period[37]. Shareholder and Capital Structure - The company issued new shares, increasing its registered capital by 21.15% to ¥143,206,000.00[19]. - The company has signed a concerted action agreement among major shareholders, ensuring unified control[34]. - The major shareholders include state-owned entities, with the largest shareholder holding 18.58% of the shares[32]. - The company has not implemented any profit distribution or capital increase from reserves during the reporting period[38]. - There were no significant related party transactions or external guarantees reported during the quarter[37]. Research and Development - The company plans to expand its market presence and invest in new product development to drive future growth[49]. - Research and development expenses for Q3 2022 were CNY 3,452,529.69, a decrease from CNY 4,442,972.26 in Q3 2021, showing a reduction of about 22.3%[54].
泰德股份(831278) - 2022 Q3 - 季度财报